(Q46881133)

26 December 2017

title

Effect of manipulating serum phosphorus with phosphate binder on circulating PTH and FGF23 in renal failure rats (English)

1 reference

26 December 2017

author name string

Nagano N

1

1 reference

26 December 2017

Miyata S

2

1 reference

26 December 2017

Abe M

3

1 reference

26 December 2017

Kobayashi N

4

1 reference

26 December 2017

Wakita S

5

1 reference

26 December 2017

Yamashita T

6

1 reference

26 December 2017

Wada M

7

1 reference

26 December 2017

language of work or name

English

0 references

publication date

1 February 2006

1 reference

26 December 2017

published in

Kidney International

1 reference

26 December 2017

volume

69

1 reference

26 December 2017

issue

3

1 reference

26 December 2017

page(s)

531-537

1 reference

26 December 2017

https://scigraph.springernature.com/pub.10.1038/sj.ki.5000020

exact match

0 references

cites work

Direct effect of phosphate on parathyroid function

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000020

7 January 2021

Mechanisms of secondary hyperparathyroidism

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000020

7 January 2021

The phosphatonin pathway: new insights in phosphate homeostasis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000020

7 January 2021

Circulating concentration of FGF-23 increases as renal function declines in patients with chronic kidney disease, but does not change in response to variation in phosphate intake in healthy volunteers

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000020

7 January 2021

FGF-23 in patients with end-stage renal disease on hemodialysis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000020

7 January 2021

Possible involvement of circulating fibroblast growth factor 23 in the development of secondary hyperparathyroidism associated with renal insufficiency.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000020

7 January 2021

Fibroblast growth factor-23 relationship to dietary phosphate and renal phosphate handling in healthy young men.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000020

7 January 2021

Circulating FGF-23 is regulated by 1alpha,25-dihydroxyvitamin D3 and phosphorus in vivo

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000020

7 January 2021

FGF-23 is a potent regulator of vitamin D metabolism and phosphate homeostasis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000020

7 January 2021

Sevelamer hydrochloride (Renagel), a non-calcaemic phosphate binder, arrests parathyroid gland hyperplasia in rats with progressive chronic renal insufficiency

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000020

7 January 2021

Sevelamer hydrochloride, a phosphate binder, protects against deterioration of renal function in rats with progressive chronic renal insufficiency

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000020

7 January 2021

Sevelamer hydrochloride prevents ectopic calcification and renal osteodystrophy in chronic renal failure rats

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000020

7 January 2021

Renal mineral handling in normal rats treated with sevelamer hydrochloride (Renagel), a noncalcemic phosphate binder

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000020

7 January 2021

Animal model of adenine-induced chronic renal failure in rats

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000020

7 January 2021

Phosphorus restriction prevents parathyroid gland growth. High phosphorus directly stimulates PTH secretion in vitro

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000020

7 January 2021

Effect of phosphate on parathyroid hormone secretion in vivo.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000020

7 January 2021

Identification of a novel fibroblast growth factor, FGF-23, preferentially expressed in the ventrolateral thalamic nucleus of the brain

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000020

7 January 2021

Cloning and characterization of FGF23 as a causative factor of tumor-induced osteomalacia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000020

7 January 2021

Regulation of fibroblastic growth factor 23 expression but not degradation by PHEX.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000020

7 January 2021

Serum fibroblast growth factor-23 levels predict the future refractory hyperparathyroidism in dialysis patients.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000020

7 January 2021

Increased circulatory level of biologically active full-length FGF-23 in patients with hypophosphatemic rickets/osteomalacia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.KI.5000020

7 January 2021

Identifiers

DOI

10.1038/SJ.KI.5000020

1 reference

26 December 2017

PubMed ID

16395276

1 reference

26 December 2017